Pimafutsin 20s 100 mg coated tablets

The instruction for medical use

of Pimafutsin® medicine

the Trade name
of Pimafutsin®

the International not patent


name Natamitsin Lekarstvennaya
the Tablet form covered with a kishechnorastvorimy cover, 100 mg

Structure
One tablet contains
active agent - natamitsin 100 mg,
excipients: potato starch, K30 povidone, magnesium stearate, lactoses monohydrate
structure of a cover: cellulose acetate phthalate, triacetin, sucrose, methylparahydroxybenzoate, calcium a carbonate, a kaolin, talc, arabic gum (acacia), gelatin, the titan dioxide (E171), Opaglos 6000, water purified.

The description
of the Tablet of round shape, white color, covered with a kishechnorastvorimy cover.

Pharmacotherapeutic group
Intestinal antimicrobial and anti-inflammatory drugs.
Antibacterial drugs. Natamitsin.
The ATX A07AA03 code

the Pharmacological

Pharmacokinetics Natamitsin properties – drug of local action, is practically not soaked up from digestive tract, through mucous membranes.
Pharmacodynamics
Antifungal half-yen antibiotic of fungicide action. Natamitsin connects sterols of cellular membranes, breaking their integrity and functions that leads to death of microorganisms. The majority of a pathogenic barmy fungi, especially Candida spp are sensitive to a natamitsin. Dermatophytes are less sensitive. The resistance to a natamitsin in clinical practice does not occur among barmy mushrooms. Natamitsin in tablets, thanks to a kishechnorastvorimy cover, acts only in intestines.

Indications
- treatment and prevention of noninvasive candidiasis of intestines
- a vulvovaginitis candidosis (as a part of complex therapy,
along with candles)


the adult appoint the Route of administration and doses In intestines candidiasis on 1 tab. 4 times/days on average, within 1 week.
To children from 6 years appoint on 1 tablet 2 times a day.
Duration of a course of treatment is 7 days.
At a persistent course of the vulvovaginitis caused by Candida albicans in addition to topical treatment (suppositories) appoint tablets inside (on 1 tab. 4 times/days within 7-10 days).
After disappearance of symptoms of a disease some more days are recommended to continue treatment.

Side effects
- nausea, vomiting, diarrhea
-

the Contraindication porphyria
- hypersensitivity to drug components
- children's age up to 6 years

Medicinal interactions
of Medicinal interactions

Special instructions
in case of persistent or recurrent infection the topical treatment is not described the suppository can be complemented with appointment.
Pregnancy and the period of a lactation
Pimafutsin's use during pregnancy and a lactation is possible.
Features of influence of medicine on ability to drive the car or other potentially dangerous mechanisms.


The Overdose does not influence
Now about cases of overdose of the drug Pimafutsin it was not reported.

The form of release and packing
On 20 tablets place in the bottles from dark glass closed by an aluminum cover with opening control.
On 1 bottle together with the instruction for medical use in the state and Russian languages place

Storage conditions in a cardboard pack
to Store at a temperature of 15 - 25 wasps.
To store out of children's reach!


4 years
not to apply a period of storage after the expiration date specified on packing.

Prescription status
According to the prescription


the Producer Astellas of Pharm Europe B.V.
Silviusveg 62, 2333 VE, Leiden, the Netherlands

the Owner of the registration certificate
Astellas of Pharm B.V. Europe, the Netherlands

the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products (goods)
RK, 050000 Almaty, Al-Farabi Ave. 15, the Centre Party of Finland of Nurla Tau,
the building 4B, office 20
Ph.: 8 (727) 311 13 90
e-mail: astellas@com.ru